CME - CME Group Inc
165
$307.32
-$3.39 (-1.091%)
$309.90
$2.58 (0.838%)
Score3.84/5
Price Targets
16.2%
0.3%
-23.8%
Most Recent Recommendations
Revenue Estimate
- Past Revenue
- Avg
- High
- Low
EPS Estimate
- Past EPS
- Avg
- High
- Low
Revenue Estimate as % change
| 2026 | 2027 | 2028 | 2029 | 2030 | |
|---|---|---|---|---|---|
| Low | 5.15% | 2.33% | 5.03% | 4.95% | 4.95% |
| Avg | 6.52% | 5.28% | 6.77% | 0.82% | 4.63% |
| High | 7.88% | 8.99% | 6.08% | -1.24% | 4.32% |
EPS Estimate as % change
| 2026 | 2027 | 2028 | 2029 | 2030 | |
|---|---|---|---|---|---|
| Low | 5.21% | 2.13% | 12.5% | 7.43% | -2.49% |
| Avg | 6.75% | 6.37% | 8.70% | 5.61% | -3.31% |
| High | 9.99% | 6.89% | 7.51% | 3.69% | -4.11% |
Recommendation Trends
- Strong Sells
- Sells
- Holds
- Buys
- Strong Buys
Latest Analyst Ratings
Institution | Action | Grade | Old Grade | Date |
|---|---|---|---|---|
| Argus Research | Downgrade | Hold | Buy | 2026-03-04 |
| RBC Capital | Maintain | Sector Perform | Sector Perform | 2026-02-05 |
| Barclays | Maintain | Equal-Weight | Equal-Weight | 2026-02-05 |
| TD Cowen | Maintain | Buy | Buy | 2026-02-05 |
| JP Morgan | Maintain | Underweight | Underweight | 2026-02-05 |
| Morgan Stanley | Maintain | Overweight | Overweight | 2026-02-05 |
| Morgan Stanley | Maintain | Overweight | Overweight | 2026-01-15 |
| TD Cowen | Upgrade | Buy | Hold | 2026-01-14 |
| Morgan Stanley | Maintain | Overweight | Overweight | 2025-12-22 |
| Barclays | Maintain | Equal-Weight | Equal-Weight | 2025-12-12 |